Interferon function is not required for recovery from a secondary poxvirus infection

被引:46
作者
Panchanathan, V [1 ]
Chaudhri, G [1 ]
Karupiah, G [1 ]
机构
[1] Australian Natl Univ, Infect & Immun Grp, Div Immunol & Genet, John Curtin Sch Med Res, Canberra, ACT 2601, Australia
关键词
antibody; CD8 T cells; ectromelia virus; IFN regulatory factor 1; type I/II IFN;
D O I
10.1073/pnas.0505180102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
IFN function is critical for recovery from most primary viral infections, including poxvirus infection. In contrast, very little is known about the requirement for IFN function in mediating recovery from a secondary virus infection. We have used ectromelia virus (ECTV), an orthopoxvirus very closely related to variola virus, to investigate the importance of IFN function in recovery from a secondary infection. Variola virus, the causative agent of smallpox in humans, and ECTV, which causes mousepox in mice, both encode receptor homologs that are thought to interfere with host IFN function. Using a prime-challenge regime, in which avirulent ECTV is used to prime mice deficient in type I/II IFN function or IFN regulatory factor 1 (IRF-1) and then challenging the mice with a virulent strain, we show that IFN function is redundant for virus clearance during a secondary ECTV infection. A neutralizing Ab response is generated in a secondary infection, even in the absence of IFN function, although when present, IFN strongly influences the neutralizing titer and subtype of IgG that is produced. Importantly, the depletion of CD8(+) T lymphocytes during a secondary challenge in IFN-deficient mice does not affect their capacity to clear ECTV, indicating that Ab is critical for the control of a secondary infection.
引用
收藏
页码:12921 / 12926
页数:6
相关论文
共 41 条
[1]   Soluble interferon-gamma receptors encoded by poxviruses [J].
Alcami, A ;
Smith, GL .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1996, 19 (04) :305-317
[2]   Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells [J].
Amara, RR ;
Nigam, P ;
Sharma, S ;
Liu, J ;
Bostik, V .
JOURNAL OF VIROLOGY, 2004, 78 (08) :3811-3816
[3]   Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model [J].
Bartlett, NW ;
Buttigieg, K ;
Kotenko, SV ;
Smith, GL .
JOURNAL OF GENERAL VIROLOGY, 2005, 86 :1589-1596
[4]   Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox [J].
Chaudhri, G ;
Panchanathan, V ;
Buller, RML ;
van den Eertwegh, AJM ;
Claassen, E ;
Zhou, J ;
de Chazal, R ;
Laman, JD ;
Karupiah, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9057-9062
[5]   Cutting edge: Long-term B cell memory in humans after smallpox vaccination [J].
Crotty, S ;
Felgner, P ;
Davies, H ;
Glidewell, J ;
Villarreal, L ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4969-4973
[6]  
DOWNIE A. W., 1958, JOUR HYGIENE, V56, P479
[7]   The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo [J].
Duncan, GS ;
Mittrucker, HW ;
Kagi, D ;
Matsuyama, T ;
Mak, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :2043-2048
[8]   Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox [J].
Earl, PL ;
Americo, JL ;
Wyatt, LS ;
Eller, LA ;
Whitbeck, JC ;
Cohen, GH ;
Eisenberg, RJ ;
Hartmann, CJ ;
Jackson, DL ;
Kulesh, DA ;
Martinez, MJ ;
Miller, DM ;
Mucker, EM ;
Shamblin, JD ;
Zwiers, SH ;
Huggins, JW ;
Jahrling, PB ;
Moss, B .
NATURE, 2004, 428 (6979) :182-185
[9]   Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus [J].
Edghill-Smith, Y ;
Golding, H ;
Manischewitz, J ;
King, LR ;
Scott, D ;
Bray, M ;
Nalca, A ;
Hooper, JW ;
Whitehouse, CA ;
Schmitz, JE ;
Reimann, KA ;
Franchini, G .
NATURE MEDICINE, 2005, 11 (07) :740-747
[10]   Duration of antiviral immunity after smallpox vaccination [J].
Hammarlund, E ;
Lewis, MW ;
Hansen, SG ;
Strelow, LI ;
Nelson, JA ;
Sexton, GJ ;
Hanifin, JM ;
Slifka, MK .
NATURE MEDICINE, 2003, 9 (09) :1131-1137